Full disclosure and regulatory approval protected the share issue against claims of fraud, misrepresentation, and improper pricing.

Full disclosure in issue documents defeated the allegation that a public share issue was misleading merely because the bank had reported losses and priced shares at a premium. The offer material disclosed the losses, risk factors, pending proceedings, market-price uncertainty, and capital restructuring; the losses were explained by prudential accounting norms and provisioning, while operating profits were shown. Regulatory approvals for the issue, premium, restructuring, and listing were also on record, so the challenge for want of approval failed. The Court treated premium fixation, accounting treatment, and related financial matters as lying within specialist regulatory expertise and declined to infer fraud or illegality absent abuse of power.

---

---

Issues: (i) whether the public issue of shares was misleading or fraudulent because the bank had shown losses and had offered shares at a premium, and (ii) whether the issue lacked the requisite approvals from the regulatory authorities.

Issue (i): whether the public issue of shares was misleading or fraudulent because the bank had shown losses and had offered shares at a premium

Analysis: The issue documents disclosed the net losses for the relevant years, the risk factors, the pending proceedings concerning an executive, the uncertainty of market price after listing, and the Government's capital restructuring and set-off of accumulated losses. The losses reflected in the accounts were explained as arising from revised prudential accounting norms and provisioning requirements, while the bank had in fact earned operating profits. On that basis, the disclosed figures and accompanying statements did not amount to concealment or deceptive projection.

Conclusion: The public issue was not shown to be fraudulent, deceptive, or vitiated by wilful misrepresentation.

Issue (ii): whether the issue lacked the requisite approvals from the regulatory authorities

Analysis: The record contained approvals and communications from the relevant authorities permitting the issue, the premium, the capital restructuring, and the listing. The disclaimer in the offer material could not displace those approvals. The fixing of premium, the accounting treatment, and related financial questions were treated as matters within the domain of specialised regulatory bodies, and the Court declined to substitute its own assessment for that of those expert authorities.

Conclusion: The challenge based on absence of regulatory approval failed.

Final Conclusion: The writ petition failed in substance because the disclosures in the issue material were held sufficient and the regulatory approvals were found to be in place.

Ratio Decidendi: Where the relevant issue documents fully disclose the material facts and the challenged financial decisions fall within the domain of specialised regulatory bodies, the Court will not infer fraud or interfere on the ground of pricing or accounting policy absent abuse of power or illegality.

---